Tandem Capital Management’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,550
| Closed | -$8.91K | – | 119 |
|
|
2025
Q1 | $8.91K | Hold |
1,550
| – | – | 0.01% | 113 |
|
|
2024
Q4 | $12.3K | Hold |
1,550
| – | – | 0.01% | 112 |
|
|
2024
Q3 | $6.32K | Hold |
1,550
| – | – | ﹤0.01% | 115 |
|
|
2024
Q2 | $7.08K | Hold |
1,550
| – | – | ﹤0.01% | 112 |
|
|
2024
Q1 | $21.4K | Hold |
1,550
| – | – | 0.01% | 109 |
|
|
2023
Q4 | $13.4K | Hold |
1,550
| – | – | 0.01% | 111 |
|
|
2023
Q3 | $13.3K | Hold |
1,550
| – | – | 0.01% | 107 |
|
|
2023
Q2 | $19.8K | Hold |
1,550
| – | – | 0.01% | 107 |
|
|
2023
Q1 | $32.6K | Hold |
1,550
| – | – | 0.02% | 105 |
|
|
2022
Q4 | $8.37K | Hold |
1,550
| – | – | 0.01% | 96 |
|
|
2022
Q3 | $10K | Hold |
1,550
| – | – | 0.01% | 91 |
|
|
2022
Q2 | $13K | Hold |
1,550
| – | – | 0.01% | 91 |
|
|
2022
Q1 | $17K | Hold |
1,550
| – | – | 0.01% | 93 |
|
|
2021
Q4 | $32K | Hold |
1,550
| – | – | 0.02% | 92 |
|
|
2021
Q3 | $44K | Buy |
+1,550
| New | +$44K | 0.03% | 87 |
|